The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Medical Thromboelastography Machine Market Research Report 2025
Synopsis
Thromboelastography (TEG) is a viscoelastic hemostatic assay that measures the visco-elastic properties of blood clot formation. It is mainly used in surgery and anesthesiology. This test is capable of measuring coagulation factor function. Some of the other tests for blood coagulation includes prothrombin time and partial thromboplastin time (aPTT). However, thromboelastography provides information regarding all components of hemostasis such as coagulation and platelet function. Also, TEG offers a particular advantage in diagnosing fibrinolysis. TEG machines are used for carrying out this test.
Global Medical Thromboelastography Machine market is projected to reach US$ 298.6 million in 2029, increasing from US$ 261 million in 2022, with the CAGR of 1.9% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Medical Thromboelastography Machine market research.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Medical Thromboelastography Machine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Aemonetics Corporation
Instrumentation Laboratory
Framar Hemologix Srl
Medirox AB
Diagnostica Stago
Life Diagnostica
SHINHUA
Haemonetics
Lepu Technology
Biomart
Medcaptain
Ud-bio
Chongqing Nanfang
WITEYE
Render
Guizhou Jinjiu Biotech
Chongqing Dingrun
Zhejiang Shengyu
Bio-zircon
WerfenLife
Sienco
Segment by Type
Single and Double Channel
Four Channels
Others
Segment by Application
Hospitals
Clinics
Blood Banks
Academic Institutes
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Medical Thromboelastography Machine report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Thromboelastography (TEG) is a viscoelastic hemostatic assay that measures the visco-elastic properties of blood clot formation. It is mainly used in surgery and anesthesiology. This test is capable of measuring coagulation factor function. Some of the other tests for blood coagulation includes prothrombin time and partial thromboplastin time (aPTT). However, thromboelastography provides information regarding all components of hemostasis such as coagulation and platelet function. Also, TEG offers a particular advantage in diagnosing fibrinolysis. TEG machines are used for carrying out this test.
Global Medical Thromboelastography Machine market is projected to reach US$ 298.6 million in 2029, increasing from US$ 261 million in 2022, with the CAGR of 1.9% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Medical Thromboelastography Machine market research.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Medical Thromboelastography Machine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Aemonetics Corporation
Instrumentation Laboratory
Framar Hemologix Srl
Medirox AB
Diagnostica Stago
Life Diagnostica
SHINHUA
Haemonetics
Lepu Technology
Biomart
Medcaptain
Ud-bio
Chongqing Nanfang
WITEYE
Render
Guizhou Jinjiu Biotech
Chongqing Dingrun
Zhejiang Shengyu
Bio-zircon
WerfenLife
Sienco
Segment by Type
Single and Double Channel
Four Channels
Others
Segment by Application
Hospitals
Clinics
Blood Banks
Academic Institutes
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Medical Thromboelastography Machine report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Medical Thromboelastography Machine Market Overview
1.1 Product Overview and Scope of Medical Thromboelastography Machine
1.2 Medical Thromboelastography Machine Segment by Type
1.2.1 Global Medical Thromboelastography Machine Market Value Comparison by Type (2023-2029)
1.2.2 Single and Double Channel
1.2.3 Four Channels
1.2.4 Others
1.3 Medical Thromboelastography Machine Segment by Application
1.3.1 Global Medical Thromboelastography Machine Market Value by Application: (2023-2029)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Blood Banks
1.3.5 Academic Institutes
1.4 Global Medical Thromboelastography Machine Market Size Estimates and Forecasts
1.4.1 Global Medical Thromboelastography Machine Revenue 2018-2029
1.4.2 Global Medical Thromboelastography Machine Sales 2018-2029
1.4.3 Global Medical Thromboelastography Machine Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Medical Thromboelastography Machine Market Competition by Manufacturers
2.1 Global Medical Thromboelastography Machine Sales Market Share by Manufacturers (2018-2023)
2.2 Global Medical Thromboelastography Machine Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Medical Thromboelastography Machine Average Price by Manufacturers (2018-2023)
2.4 Global Medical Thromboelastography Machine Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Medical Thromboelastography Machine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Medical Thromboelastography Machine, Product Type & Application
2.7 Medical Thromboelastography Machine Market Competitive Situation and Trends
2.7.1 Medical Thromboelastography Machine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Medical Thromboelastography Machine Players Market Share by Revenue
2.7.3 Global Medical Thromboelastography Machine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Medical Thromboelastography Machine Retrospective Market Scenario by Region
3.1 Global Medical Thromboelastography Machine Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Medical Thromboelastography Machine Global Medical Thromboelastography Machine Sales by Region: 2018-2029
3.2.1 Global Medical Thromboelastography Machine Sales by Region: 2018-2023
3.2.2 Global Medical Thromboelastography Machine Sales by Region: 2024-2029
3.3 Global Medical Thromboelastography Machine Global Medical Thromboelastography Machine Revenue by Region: 2018-2029
3.3.1 Global Medical Thromboelastography Machine Revenue by Region: 2018-2023
3.3.2 Global Medical Thromboelastography Machine Revenue by Region: 2024-2029
3.4 North America Medical Thromboelastography Machine Market Facts & Figures by Country
3.4.1 North America Medical Thromboelastography Machine Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Medical Thromboelastography Machine Sales by Country (2018-2029)
3.4.3 North America Medical Thromboelastography Machine Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Medical Thromboelastography Machine Market Facts & Figures by Country
3.5.1 Europe Medical Thromboelastography Machine Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Medical Thromboelastography Machine Sales by Country (2018-2029)
3.5.3 Europe Medical Thromboelastography Machine Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Medical Thromboelastography Machine Market Facts & Figures by Country
3.6.1 Asia Pacific Medical Thromboelastography Machine Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Medical Thromboelastography Machine Sales by Country (2018-2029)
3.6.3 Asia Pacific Medical Thromboelastography Machine Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Medical Thromboelastography Machine Market Facts & Figures by Country
3.7.1 Latin America Medical Thromboelastography Machine Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Medical Thromboelastography Machine Sales by Country (2018-2029)
3.7.3 Latin America Medical Thromboelastography Machine Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Medical Thromboelastography Machine Market Facts & Figures by Country
3.8.1 Middle East and Africa Medical Thromboelastography Machine Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Medical Thromboelastography Machine Sales by Country (2018-2029)
3.8.3 Middle East and Africa Medical Thromboelastography Machine Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Medical Thromboelastography Machine Sales by Type (2018-2029)
4.1.1 Global Medical Thromboelastography Machine Sales by Type (2018-2023)
4.1.2 Global Medical Thromboelastography Machine Sales by Type (2024-2029)
4.1.3 Global Medical Thromboelastography Machine Sales Market Share by Type (2018-2029)
4.2 Global Medical Thromboelastography Machine Revenue by Type (2018-2029)
4.2.1 Global Medical Thromboelastography Machine Revenue by Type (2018-2023)
4.2.2 Global Medical Thromboelastography Machine Revenue by Type (2024-2029)
4.2.3 Global Medical Thromboelastography Machine Revenue Market Share by Type (2018-2029)
4.3 Global Medical Thromboelastography Machine Price by Type (2018-2029)
5 Segment by Application
5.1 Global Medical Thromboelastography Machine Sales by Application (2018-2029)
5.1.1 Global Medical Thromboelastography Machine Sales by Application (2018-2023)
5.1.2 Global Medical Thromboelastography Machine Sales by Application (2024-2029)
5.1.3 Global Medical Thromboelastography Machine Sales Market Share by Application (2018-2029)
5.2 Global Medical Thromboelastography Machine Revenue by Application (2018-2029)
5.2.1 Global Medical Thromboelastography Machine Revenue by Application (2018-2023)
5.2.2 Global Medical Thromboelastography Machine Revenue by Application (2024-2029)
5.2.3 Global Medical Thromboelastography Machine Revenue Market Share by Application (2018-2029)
5.3 Global Medical Thromboelastography Machine Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Aemonetics Corporation
6.1.1 Aemonetics Corporation Corporation Information
6.1.2 Aemonetics Corporation Description and Business Overview
6.1.3 Aemonetics Corporation Medical Thromboelastography Machine Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Aemonetics Corporation Medical Thromboelastography Machine Product Portfolio
6.1.5 Aemonetics Corporation Recent Developments/Updates
6.2 Instrumentation Laboratory
6.2.1 Instrumentation Laboratory Corporation Information
6.2.2 Instrumentation Laboratory Description and Business Overview
6.2.3 Instrumentation Laboratory Medical Thromboelastography Machine Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Instrumentation Laboratory Medical Thromboelastography Machine Product Portfolio
6.2.5 Instrumentation Laboratory Recent Developments/Updates
6.3 Framar Hemologix Srl
6.3.1 Framar Hemologix Srl Corporation Information
6.3.2 Framar Hemologix Srl Description and Business Overview
6.3.3 Framar Hemologix Srl Medical Thromboelastography Machine Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Framar Hemologix Srl Medical Thromboelastography Machine Product Portfolio
6.3.5 Framar Hemologix Srl Recent Developments/Updates
6.4 Medirox AB
6.4.1 Medirox AB Corporation Information
6.4.2 Medirox AB Description and Business Overview
6.4.3 Medirox AB Medical Thromboelastography Machine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Medirox AB Medical Thromboelastography Machine Product Portfolio
6.4.5 Medirox AB Recent Developments/Updates
6.5 Diagnostica Stago
6.5.1 Diagnostica Stago Corporation Information
6.5.2 Diagnostica Stago Description and Business Overview
6.5.3 Diagnostica Stago Medical Thromboelastography Machine Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Diagnostica Stago Medical Thromboelastography Machine Product Portfolio
6.5.5 Diagnostica Stago Recent Developments/Updates
6.6 Life Diagnostica
6.6.1 Life Diagnostica Corporation Information
6.6.2 Life Diagnostica Description and Business Overview
6.6.3 Life Diagnostica Medical Thromboelastography Machine Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Life Diagnostica Medical Thromboelastography Machine Product Portfolio
6.6.5 Life Diagnostica Recent Developments/Updates
6.7 SHINHUA
6.6.1 SHINHUA Corporation Information
6.6.2 SHINHUA Description and Business Overview
6.6.3 SHINHUA Medical Thromboelastography Machine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 SHINHUA Medical Thromboelastography Machine Product Portfolio
6.7.5 SHINHUA Recent Developments/Updates
6.8 Haemonetics
6.8.1 Haemonetics Corporation Information
6.8.2 Haemonetics Description and Business Overview
6.8.3 Haemonetics Medical Thromboelastography Machine Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Haemonetics Medical Thromboelastography Machine Product Portfolio
6.8.5 Haemonetics Recent Developments/Updates
6.9 Lepu Technology
6.9.1 Lepu Technology Corporation Information
6.9.2 Lepu Technology Description and Business Overview
6.9.3 Lepu Technology Medical Thromboelastography Machine Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Lepu Technology Medical Thromboelastography Machine Product Portfolio
6.9.5 Lepu Technology Recent Developments/Updates
6.10 Biomart
6.10.1 Biomart Corporation Information
6.10.2 Biomart Description and Business Overview
6.10.3 Biomart Medical Thromboelastography Machine Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Biomart Medical Thromboelastography Machine Product Portfolio
6.10.5 Biomart Recent Developments/Updates
6.11 Medcaptain
6.11.1 Medcaptain Corporation Information
6.11.2 Medcaptain Medical Thromboelastography Machine Description and Business Overview
6.11.3 Medcaptain Medical Thromboelastography Machine Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Medcaptain Medical Thromboelastography Machine Product Portfolio
6.11.5 Medcaptain Recent Developments/Updates
6.12 Ud-bio
6.12.1 Ud-bio Corporation Information
6.12.2 Ud-bio Medical Thromboelastography Machine Description and Business Overview
6.12.3 Ud-bio Medical Thromboelastography Machine Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Ud-bio Medical Thromboelastography Machine Product Portfolio
6.12.5 Ud-bio Recent Developments/Updates
6.13 Chongqing Nanfang
6.13.1 Chongqing Nanfang Corporation Information
6.13.2 Chongqing Nanfang Medical Thromboelastography Machine Description and Business Overview
6.13.3 Chongqing Nanfang Medical Thromboelastography Machine Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Chongqing Nanfang Medical Thromboelastography Machine Product Portfolio
6.13.5 Chongqing Nanfang Recent Developments/Updates
6.14 WITEYE
6.14.1 WITEYE Corporation Information
6.14.2 WITEYE Medical Thromboelastography Machine Description and Business Overview
6.14.3 WITEYE Medical Thromboelastography Machine Sales, Revenue and Gross Margin (2018-2023)
6.14.4 WITEYE Medical Thromboelastography Machine Product Portfolio
6.14.5 WITEYE Recent Developments/Updates
6.15 Render
6.15.1 Render Corporation Information
6.15.2 Render Medical Thromboelastography Machine Description and Business Overview
6.15.3 Render Medical Thromboelastography Machine Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Render Medical Thromboelastography Machine Product Portfolio
6.15.5 Render Recent Developments/Updates
6.16 Guizhou Jinjiu Biotech
6.16.1 Guizhou Jinjiu Biotech Corporation Information
6.16.2 Guizhou Jinjiu Biotech Medical Thromboelastography Machine Description and Business Overview
6.16.3 Guizhou Jinjiu Biotech Medical Thromboelastography Machine Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Guizhou Jinjiu Biotech Medical Thromboelastography Machine Product Portfolio
6.16.5 Guizhou Jinjiu Biotech Recent Developments/Updates
6.17 Chongqing Dingrun
6.17.1 Chongqing Dingrun Corporation Information
6.17.2 Chongqing Dingrun Medical Thromboelastography Machine Description and Business Overview
6.17.3 Chongqing Dingrun Medical Thromboelastography Machine Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Chongqing Dingrun Medical Thromboelastography Machine Product Portfolio
6.17.5 Chongqing Dingrun Recent Developments/Updates
6.18 Zhejiang Shengyu
6.18.1 Zhejiang Shengyu Corporation Information
6.18.2 Zhejiang Shengyu Medical Thromboelastography Machine Description and Business Overview
6.18.3 Zhejiang Shengyu Medical Thromboelastography Machine Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Zhejiang Shengyu Medical Thromboelastography Machine Product Portfolio
6.18.5 Zhejiang Shengyu Recent Developments/Updates
6.19 Bio-zircon
6.19.1 Bio-zircon Corporation Information
6.19.2 Bio-zircon Medical Thromboelastography Machine Description and Business Overview
6.19.3 Bio-zircon Medical Thromboelastography Machine Sales, Revenue and Gross Margin (2018-2023)
6.19.4 Bio-zircon Medical Thromboelastography Machine Product Portfolio
6.19.5 Bio-zircon Recent Developments/Updates
6.20 WerfenLife
6.20.1 WerfenLife Corporation Information
6.20.2 WerfenLife Medical Thromboelastography Machine Description and Business Overview
6.20.3 WerfenLife Medical Thromboelastography Machine Sales, Revenue and Gross Margin (2018-2023)
6.20.4 WerfenLife Medical Thromboelastography Machine Product Portfolio
6.20.5 WerfenLife Recent Developments/Updates
6.21 Sienco
6.21.1 Sienco Corporation Information
6.21.2 Sienco Medical Thromboelastography Machine Description and Business Overview
6.21.3 Sienco Medical Thromboelastography Machine Sales, Revenue and Gross Margin (2018-2023)
6.21.4 Sienco Medical Thromboelastography Machine Product Portfolio
6.21.5 Sienco Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Medical Thromboelastography Machine Industry Chain Analysis
7.2 Medical Thromboelastography Machine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Medical Thromboelastography Machine Production Mode & Process
7.4 Medical Thromboelastography Machine Sales and Marketing
7.4.1 Medical Thromboelastography Machine Sales Channels
7.4.2 Medical Thromboelastography Machine Distributors
7.5 Medical Thromboelastography Machine Customers
8 Medical Thromboelastography Machine Market Dynamics
8.1 Medical Thromboelastography Machine Industry Trends
8.2 Medical Thromboelastography Machine Market Drivers
8.3 Medical Thromboelastography Machine Market Challenges
8.4 Medical Thromboelastography Machine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
